abstract |
-84-description Abstract the present invention relates to novel compounds of formula (I), wherein R is 1 、R 2 、R 3 、R 4 、R 5 And R 6 As described herein, to their pharmaceutically acceptable 5 salts, enantiomers or diastereomers thereof, as well as compositions comprising and methods of using the same. |